Kevin Fischbeck
Stock Analyst at B of A Securities
(3.96)
# 607
Out of 5,117 analysts
189
Total ratings
65.41%
Success rate
5.56%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $32.58 | +7.43% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $14.69 | -11.50% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $9.22 | +8.46% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $258.83 | +15.91% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $349.88 | +5.75% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $331.83 | +17.53% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $16.10 | +11.80% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $113.98 | +22.83% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $200.60 | +12.16% | 7 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $107.52 | +48.81% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $30 | $40.51 | -25.94% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $227.64 | -18.73% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $477.13 | -14.07% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $0.73 | +313.34% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $164.84 | +166.32% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $10.25 | -36.59% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $18.78 | -61.40% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $276.51 | +26.58% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $15.87 | +183.55% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.23 | +70.28% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $14.77 | +136.97% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.51 | +298.41% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $8.00 | -6.25% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $21.87 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $26.90 | -29.37% | 2 | Feb 9, 2018 |
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $32.58
Upside: +7.43%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $14.69
Upside: -11.50%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $9.22
Upside: +8.46%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $258.83
Upside: +15.91%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $349.88
Upside: +5.75%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $331.83
Upside: +17.53%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $16.10
Upside: +11.80%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $113.98
Upside: +22.83%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $200.60
Upside: +12.16%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $107.52
Upside: +48.81%
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $40.51
Upside: -25.94%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $227.64
Upside: -18.73%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $477.13
Upside: -14.07%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.73
Upside: +313.34%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $164.84
Upside: +166.32%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $10.25
Upside: -36.59%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $18.78
Upside: -61.40%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $276.51
Upside: +26.58%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $15.87
Upside: +183.55%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.23
Upside: +70.28%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $14.77
Upside: +136.97%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.51
Upside: +298.41%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $8.00
Upside: -6.25%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $21.87
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $26.90
Upside: -29.37%